Antibodies as biological markers for pathophysiological processes in MS
- 1 November 2006
- journal article
- review article
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 180 (1-2) , 50-62
Abstract
No abstract availableKeywords
This publication has 116 references indexed in Scilit:
- Antimyelin antibodies and the risk of relapse in patients with a primary demyelinating eventJournal of Neurology, Neurosurgery & Psychiatry, 2006
- IMMUNOLOGY OF MULTIPLE SCLEROSISAnnual Review of Immunology, 2005
- A human antibody that promotes remyelination enters the CNS and decreases lesion load as detected by T2‐weighted spinal cord MRI in a virus‐induced murine model of MSThe FASEB Journal, 2004
- Nogo and axon regenerationCurrent Opinion in Neurobiology, 2004
- Antibodies reactive to heat shock protein 90 induce oligodendrocyte precursor cell death in culture. Implications for demyelination in multiple sclerosisThe FASEB Journal, 2003
- Anti-MOG and anti-MBP antibody subclasses in multiple sclerosisMultiple Sclerosis Journal, 2001
- The intrathecal, polyspecific and oligoclonal immune response in multiple sclerosisMultiple Sclerosis Journal, 1998
- Myelin/oligodendrocyte glycoprotein is a unique member of the immunoglobulin superfamilyJournal of Neuroscience Research, 1992
- Antibodies to myelin-oligodendrocyte glycoprotein in cerebrospinal fluid from patients with multiple sclerosis and controlsJournal of Neuroimmunology, 1991
- Antibody responses in chronic relapsing experimental allergic encephalomyelitis: correlation of serum demyelinating activity with antibody titre to the myelin/oligodendrocyte glycoprotein (MOG)Journal of Neuroimmunology, 1987